Rockefeller Capital Management’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
Rockefeller Capital Management's IMNM Position: Q3 2026 in Review
Rockefeller Capital Management increased its Immunome (IMNM) stake by 5,000% in Q3 2026, buying an estimated $4.96K and bringing the position to 204 shares worth $4.39K. The position accounts for ﹤0.01% of the portfolio, ranked #4417.
Rockefeller Capital Management first reported a position in IMNM in Q1 2021 and has held it in 8 quarters since. 211 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.
- Rockefeller Capital Management held 204 shares of Immunome worth $4.39K as of Q3 2026.
- Rockefeller Capital Management bought 200 Immunome shares in Q3 2026, an estimated $4.96K.
- Immunome made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4417 holding.
- Rockefeller Capital Management first reported a position in Immunome in Q1 2021 and has held it in 8 quarters since.
- 211 funds tracked by Wall St. Rank held Immunome as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.